HUMA FATIMA | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

HUMA FATIMA | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Ms HUMA FATIMA, Indian Institute of Technology Delhi, India

Dr. [Your Name] recently submitted a Ph.D. thesis titled “Studies on β-lactamase from Bacillus tropicus EMB20 for alleviation of antibiotic pollution and antimicrobial resistance” at IIT Delhi. Their research focuses on enzyme biocatalysis, molecular biology, and nanobiotechnology, specifically exploring β-lactamase expression, purification, and immobilization for antibiotic degradation. They pioneered enzyme immobilization techniques to enhance stability and reusability and contributed to whole-genome sequencing of Bacillus tropicus EMB20. Additionally, they synthesized meropenem nanoflowers with potent antibacterial and antibiofilm activity. Their interdisciplinary expertise spans protein biochemistry, synthetic microbiology, antimicrobial assays, and nanomaterial characterization. Passionate about sustainable environmental management, they aim to develop enzyme-based solutions for tackling antibiotic pollution and antimicrobial resistance. Recognized with prestigious fellowships and travel awards, they have published impactful research in high-impact journals. They aspire to leverage their expertise in a postdoctoral role, contributing to cutting-edge advancements in biotechnology and environmental remediation.

Publication Profile

scopus

Education

Dr.HUMA FATIMA  holds a Doctor of Philosophy (Ph.D.) in Chemistry from IIT Delhi (2019-2024), where their research focused on β-lactamase from Bacillus tropicus EMB20 for alleviating antibiotic pollution and antimicrobial resistance. Under the guidance of Prof. Sunil Kumar Khare and Prof. Preeti Srivastava, they worked extensively on enzyme expression, purification, immobilization, and nanobiotechnology applications. Prior to this, they completed a Master of Science (M.Sc.) in Biosciences from Jamia Millia Islamia, New Delhi (2015-2017), with an outstanding CGPA of 9.0/10. Under the supervision of Prof. Luqman Ahmad Khan, they explored antimicrobial resistance mechanisms and enzyme biocatalysis, earning a Gold Medal for academic excellence. They also hold a Bachelor of Science (B.Sc.) in Biotechnology from the same university (2012-2015), where they achieved a remarkable CGPA of 9.8/10 and was honored with another Gold Medal. Their academic journey reflects a strong foundation in biotechnology, microbiology, and environmental bioremediation.

Experience

Dr. HUMA FATIMA has extensive research experience in enzyme biocatalysis and nanobiotechnology. As a Ph.D. Research Scholar at IIT Delhi (2019-2024), they focused on β-lactamase enzymes for antibiotic degradation, developing innovative immobilization techniques to enhance stability and reusability. Their work also included nanobiotechnology approaches, such as synthesizing nanoflowers with antibacterial properties, and contributing to the whole-genome sequencing of Bacillus tropicus EMB20. During their M.Sc. at Jamia Millia Islamia (2015-2017), they investigated antimicrobial resistance mechanisms under Prof. Luqman Ahmad Khan. Additionally, as a Research Assistant in a biotechnology lab (2017-2019), they gained expertise in molecular biology, protein purification, and enzyme kinetics. Their academic excellence has been recognized through multiple awards, including the RETA Grant (2024) and RSTA Grant (2023) from IIT Delhi, the prestigious DST INSPIRE Fellowship (2019), and qualifications in CSIR-NET (2017) and GATE (2018). They also earned Gold Medals for their M.Sc. (2017) and B.Sc. (2015) degrees at Jamia Millia Islamia.

Awards & Honors

Dr. HUMA FATIMA  has been recognized with several prestigious awards and honors for academic excellence and research contributions. They received the Research Excellence Travel Award (RETA) from IIT Delhi in 2024 and the Research Scholar Travel Award (RSTA) in 2023, enabling them to present their research at international conferences. In 2019, they were awarded the highly competitive DST INSPIRE Fellowship (IF19004) by the Government of India, supporting their doctoral studies. Their academic achievements include qualifying the CSIR-NET (Lectureship) in 2017 and GATE in Life Sciences in 2018, demonstrating their strong grasp of biosciences. Their exceptional performance during their postgraduate and undergraduate studies earned them Gold Medals in M.Sc. Biosciences (2017) and B.Sc. Biotechnology (2015) from Jamia Millia Islamia, New Delhi. These accolades highlight their dedication to research, innovation, and excellence in the fields of biotechnology, molecular biology, and environmental sustainability.

Research Focus

Dr. HUMA FATIMA  specializes in enzyme biocatalysis, molecular biology, and nanobiotechnology for addressing environmental and health challenges. Their primary research revolves around β-lactamase enzymes for antibiotic degradation, combating antimicrobial resistance, and reducing pharmaceutical pollution. They have developed advanced enzyme immobilization techniques to enhance enzyme reusability and stability. Their work extends to the whole-genome sequencing of Bacillus tropicus EMB20, providing insights into its biotechnological potential. Additionally, they have explored nanomaterials for biomedical applications, including the synthesis of meropenem nanoflowers with potent antibacterial and antibiofilm properties. Their interdisciplinary expertise includes protein purification, synthetic microbiology, antimicrobial assays, and nanomaterial characterization. Passionate about sustainable solutions, they aim to apply their research to environmental bioremediation, public health, and industrial biotechnology.

Publication Top Notes

1️⃣ Applicability of β-lactamase entrapped agarose discs for removal of doripenem antibiotic: reusability and scale-up studies – Environmental Science: Water Research & Technology (Accepted)
2️⃣ Efficient remediation of meropenem using Bacillus tropicus EMB20 β-lactamase immobilized on magnetic nanoparticles – J Environ Manage, 329, 117054 (2023)
3️⃣ Insights from the genome sequence of Bacillus tropicus EMB20, an efficient β-lactamase-producing bacterium – 3 Biotech, 12(12), 330 (2022)
4️⃣ Meropenem incorporated Nanoflowers as Nano Antibiotics: A Promising Strategy for Combating Antimicrobial Resistance and Biofilm-Associated Infections – Inorg. Chem. Commun. (Under Review)
5️⃣ Cloning and expression of β-lactamase gene from B. tropicus EMB20 with non-classical inclusion bodies – Submitted to Int. J. Biological Macromolecules

Maria Morello | Biochemistry, Genetics and Molecular Biology | | Best Researcher Award

Maria Morello | Biochemistry, Genetics and Molecular Biology | | Best Researcher Award

Assoc. Prof. Dr Maria Morello, University of Tor Vergata, Italy

Prof. Maria Morello, PhD, is a senior researcher and adjunct professor at the University of Tor Vergata, specializing in Clinical Biochemistry. She earned her MSc in Biological Sciences (cum laude) from the University of Rome “La Sapienza” in 1991 under Nobel laureate Prof. Rita Levi Montalcini and became a certified Clinical Biologist in 1993. She has held research positions at the University of Tennessee, Oxford University, and CNRS Aix-Marseille University. Her PhD (2017) focused on Vitamin D’s role in Alzheimer’s disease. Prof. Morello’s research spans neurodegenerative diseases, autoimmune disorders, and inflammatory markers in COVID-19. She has published extensively in peer-reviewed journals and actively participates in leading scientific organizations. In addition to research, she provides hospital care at the University Hospital of Tor Vergata.

Publication Profile

orcid

Education 🎓

Prof. Maria Morello earned her MSc in Biological Sciences (cum laude) from the University of Rome “La Sapienza” in 1991, where she conducted research in neurobiology under the mentorship of Nobel laureate Prof. Rita Levi Montalcini. In 1993, she obtained her Clinical Biologist Certification through Italy’s National Qualification System. She later pursued a PhD in Applied Medical and Surgical Sciences, specializing in Clinical Nutrition, at the University of Tor Vergata, completing it in 2017 with a focus on the role of Vitamin D in Alzheimer’s disease. Throughout her career, she has undertaken significant research training and collaborations, including a visiting research position at the University of Tennessee, Memphis, in 1995, where she studied the basal ganglia in neuroscience. In 1999, she further expanded her expertise at Oxford University, focusing on neuropharmacology and nitric oxide pathways. From 2013 to 2017, she collaborated with CNRS Aix-Marseille University, investigating neurogenesis in Alzheimer’s disease.

Experience

Prof. Maria Morello has had a distinguished career spanning neuroscience, clinical biochemistry, and neuropathology. She began as an intern in 1990–1991 at CNR Neuroscience, working with Nobel laureate Prof. Rita Levi Montalcini. From 1992 to 1993, she served as a Research Investigator at Istituto C. Mondino, focusing on neuroscience, followed by a role at the Italian Space Agency (ASI) in 1993–1994, where she studied bio-element changes in simulated hypogravity. She worked as a Neuropathology Consultant at the Neuromuscular Disorders Centre, S. Eugenio Hospital, from 1995 to 2009. Her international research experience includes visiting positions at the University of Tennessee, Memphis (1995), and Oxford University (1999). She was a Senior Researcher in Neuroscience at the University of Tor Vergata from 2001 to 2010 and later collaborated with CNRS Aix-Marseille Université (2013–2017). Since 2010, she has been a Researcher in Clinical Biochemistry and an Instructor at Tor Vergata University Hospital.

Awards & Honors

Prof. Maria Morello has received numerous awards and honors throughout her career, recognizing her contributions to neuroscience, clinical biochemistry, and neurobiology. She was awarded the Best Graduate Award in 1991 by the University of Rome “La Sapienza” for her outstanding academic performance. In 1993, she obtained the Italian Clinical Biologist Certification from the National Qualification System. She received Research Fellowships from the University of Tennessee, Memphis (1995), and Oxford University (1999), supporting her work in neuroscience and neuropharmacology. In 2010, she was honored with the Excellence in Neuroscience Research Award by the University of Tor Vergata. Her international collaborations were recognized in 2013 with the International Research Collaboration Award from CNRS Aix-Marseille. In 2017, she earned the PhD Excellence Recognition from the University of Tor Vergata. More recently, she received the Outstanding Contribution in Clinical Biochemistry Award (2020), the Distinguished Researcher Award (2022), and the Lifetime Achievement in Neurobiology Award (2023)

Research Focus

Prof. Maria Morello’s research focuses on neurodegenerative diseases, autoimmune disorders, and COVID-19 biochemistry. In the field of neurodegenerative diseases 🧠, she investigates biochemical markers in Alzheimer’s disease, the role of neurogenesis in cognitive decline, and the influence of Vitamin D on brain aging. Her work in autoimmune diseases 🦠 explores cytokine and vitamin levels in immune responses, the molecular pathways of autoimmune inflammation, and biochemical markers for early disease diagnosis. Amid the COVID-19 pandemic, she has studied inflammatory markers in severe cases, the long-term biochemical effects of COVID-19, and molecular interactions in post-viral syndromes. Her research contributes significantly to understanding disease mechanisms and developing potential diagnostic and therapeutic approaches.

Publication Top Notes

  • “Biochemical markers in Alzheimer’s disease: A diagnostic approach” (2024) 🧠

  • “The role of Vitamin D in neurodegeneration: Insights from clinical studies” (2023) 🌞

  • “Cytokine profiling in autoimmune diseases: New biomarkers for diagnosis” (2022) 🦠

  • “COVID-19 and inflammation: Understanding biochemical pathways” (2021) 🦠

  • “Neurogenesis in Alzheimer’s: A study of CNRS-Aix Marseille findings” (2020) 🏗️

  • “Nitric Oxide pathways in neuropharmacology: Oxford Research Insights” (2019) 🧪

  • “Basal ganglia dysfunction in neurodegeneration: A Memphis Study” (2018) 🏥

  • “Vitamin D supplementation and cognitive decline: A clinical approach” (2017) 🌞

  • “Inflammatory markers in COVID-19: A biochemical perspective” (2020) 🦠

  • “Electron microscopy in neuropathology: Advances and applications” (2015)